article thumbnail

Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’

pharmaphorum

Swiss medical data specialist Sophia Genetics has launched a platform that will sift through data generated at more than 1,000 hospitals around the world to try to work out how the COVID-19 pandemic will evolve in the coming months and years. The post Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’ appeared first on.

Genetics 136
article thumbnail

Scrutinizing the West Syndrome Market Space from Growth Perspectives

Delveinsight

It can be due to the previous existence of brain damage signs (psychomotor retardation, neurologic signs, radiologic signs, or other types of seizures) or on the basis of etiology that is characterized by a lack of previous signs of brain damage. There are many different causes of epileptic spasms. before the onset of the spasm.

article thumbnail

What will the 2023 drug discovery landscape look like?

Drug Discovery World

But Jeffrey Petrella, Professor of Radiology and Director of the Alzheimer Imaging Research Laboratory at Duke University School of Medicine, says: “Despite these limitations, this is the first step towards tailored clinical trials.